İLKOPOL

A trailblazer in healthcare, ILKO PHARMACEUTICALS aims to pioneer the production of Non-Sterile High-Potency medicine, a rare and challenging endeavor in Türkiye, through its investment in İLKOPOL. Situated in Çerkezköy, İLKOPOL is ILKO Pharmaceuticals' new production facility for cytotoxic products and was established with domestic capital. İLKO Pharmaceuticals has entered the oncology and TNF market with a robust product portfolio and continues to expand its offerings in this sector.

In addition to providing high-quality and assured treatment options for patients and physicians, ILKO Pharmaceuticals aims to locally produce non-sterile high-potency products that are mainly imported. This initiative will contribute significantly to the national economy. Furthermore, the İLKOPOL Production Facility will not only cater to ILKO Pharmaceuticals' products but also extend Contract Manufacturing Organization (CMO) support to other national and international pharmaceutical companies.